Additionally, using a tandem mRFP-GFP tagged LC3 construct, we found that brigatinib-treated CRC cells displayed more autolysosomes (GFP-RFP+ signal) than autophagosomes (GFP+RFP+ signal) (Figure S5C-D). The gene discussed is MAP1LC3A; the disease is colorectal carcinoma.